PT-141 (Bremelanotide) Pen 10mg / 2ml

PT-141 (bremelanotide) is a melanocortin-4 receptor agonist that acts centrally on sexual-desire pathways rather than on vascular tone. It is approved in the US for hypoactive sexual desire disorder in premenopausal women (RECONNECT trials, Obstet Gynecol 2019).

The only compound in this category with a central mechanism, relevant when the issue is desire rather than blood flow.

Presentation

• Format: Pre-filled injection pen
• Strength: 10mg / 2ml
• Storage: refrigerate at 2–8 °C; keep away from light

Supplied to healthcare professionals and their patients for use under medical supervision. Product information is educational and does not replace clinical judgement.